The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Anti- Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease
Open accessAbstract
Background and aims: Several antibodies have been reported in the sera of patients with Crohn’s disease (CD) and ulcerative colitis (UC). The most commonly described are anti- Saccharomyces cerevisiae mannan antibodies (ASCA) in CD and perinuclear antineutrophil cytoplasm antibodies (pANCA) in UC. Familial clustering of these antibodies has been described, suggesting they might be genetic markers. Our aim was to investigate the presence of these antibodies before the emergence of overt clinical manifestations. Methods: Since 1980, the Israeli Defense Force (IDF) Medical Corps Serum Repository has stored serum samples obtained systematically from 5% of all recruits on enlistment, and from the same population on discharge from compulsory military service. We evaluated serum samples obtained from 32 subjects with CD and eight with UC before they were clinically diagnosed, along with samples from matched controls. Results: ASCA were present in 10/32 (31.3%) CD patients before clinical diagnosis compared with 0/95 (0%) controls (p<0.001). None of the eight patients with serum samples available before diagnosis of UC were ASCA positive. ASCA was positive in 54.5% of patients after diagnosis of CD. The mean interval between ASCA detection and diagnosis was 38 months. In 90% of patients, antibodies were detected in the first available serum sample; therefore, measurements of the average time from the presence of ASCA to diagnosis may be even longer. pANCA were present in 2/8 (25%) patients with available sera before the diagnosis of UC. None of their 24 matched controls were positive (p = 0.014). Conclusions: ASCA and pANCA may predict development of inflammatory bowel disease years before the disease is clinically diagnosed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A., & Harley, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021933 · Cited by 2,578
Nielen, M. M. J., van Schaardenburg, D., Reesink, H. W., van de Stadt, R. J., van der Horst‐Bruinsma, I. E., de Koning, M. H. M. T., Habibuw, M. R., Vandenbroucke, J. P., & Dijkmans, B. A. C. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20018 · Cited by 1,861
Renal-Limited “Lupus-Like” Nephritis: How Much of a Lupus
Maziad, A. S. A., Torrealba, J., Seikaly, M. G., Hassler, J. R., & Hendricks, A. R. (2017) · Case Reports in Nephrology and Dialysis · doi:10.1159/000475493 · Cited by 1,299
Quinton, J.-F., Sendid, B., Reumaux, D., Duthilleul, P., Cortot, A., Grandbastien, B., Charrier, G., Targan, S. R., Colombel, J.-F., & Poulain, D. (1998) · Gut · doi:10.1136/gut.42.6.788 · Cited by 575
Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease
Ruemmele, F. M., Targan, S. R., Levy, G., Dubinsky, M., Braun, J., & Seidman, E. G. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70252-5 · Cited by 379
Vasiliauskas, E. A., Kam, L. Y., Karp, L. C., Gaiennie, J., Yang, H., & Targan, S. R. (2000) · Gut · doi:10.1136/gut.47.4.487 · Cited by 312
Clustering of increased small intestinal permeability in families with Crohn's disease
Peeters, M., Geypens, B., Claus, D., Nevens, H., Ghoos, Y., Verbeke, G., Baert, F., Vermeire, S., Vlietinck, R., & Rutgeerts, P. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70174-4 · Cited by 261
Autoantibodies as predictors of disease
Scofield, R. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16154-0 · Cited by 246
Specific antibody response to oligomannosidic epitopes in Crohn's disease
Sendid, B., Colombel, J. F., Jacquinot, P. M., Faille, C., Fruit, J., Cortot, A., Lucidarme, D., Camus, D., & Poulain, D. (1996) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.3.2.219-226.1996 · Cited by 239
Vermeire, S., Peeters, M., Vlietinck, R., Joossens, S., Hond, E. D., Bulteel, V., Bossuyt, X., Geypens, B., & Rutgeerts, P. (2001) · Inflammatory Bowel Disease · doi:10.1097/00054725-200102000-00002 · Cited by 185
Seibold, F., Weber, P., Klein, R., Berg, P. A., & Wiedmann, K. H. (1992) · Gut · doi:10.1136/gut.33.5.657 · Cited by 184
LaGasse, J. M., Brantley, M. S., Leech, N. J., Rowe, R. E., Monks, S., Palmer, J. P., Nepom, G. T., McCulloch, D. K., & Hagopian, W. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.505 · Cited by 172
Sandborn, W. J., Loftus, E. V., Colombel, J. F., Fleming, K. A., Seibold, F., Homburger, H. A., Sendid, B., Chapman, R. W., Tremaine, W. J., Kaul, D. K., et al. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200108000-00003 · Cited by 165
Forcione, D. G., Rosen, M. J., Kisiel, J. B., & Sands, B. E. (2004) · Gut · doi:10.1136/gut.2003.030734 · Cited by 136
Development of Anti‐dsDNA Autoantibodies Prior to Clinical Diagnosis of Systemic Lupus Erythematosus
Arbuckle, M. R., James, J. A., Kohlhase, K. F., Rubertone, M. V., Dennis, G. J., & Harley, J. B. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.00959.x · Cited by 130
Targan, S. R., Landers, C. J., Cobb, L. M., MacDermott, R. P., & Vidrich, A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.6.3262 · Cited by 110
Anti-Saccharomyces cerevisiae Antibodies in Inflammatory Bowel Disease: a Family Study
Seibold, F., Stich, O., Hufnagl, R., Kamil, S., & Scheurlen, M. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201750065960 · Cited by 87
Annese, V., Andreoli, A., Andriulli, A., Renata D'Incà, Gionchetti, P., Latiano, A., Lombardi, G., Piepoli, A., Poulain, D., Sendid, B., et al. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02606-5 · Cited by 78
Serological markers in inflammatory bowel diseases
Reumaux, D., Sendid, B., Poulain, D., Duthilleul, P., Dewit, O., & Colombel, J. (2003) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0347 · Cited by 75
Intestinal permeability in Crohn's disease patients and their first degree relatives
Secondulfo, M., de Magistris, L., Fiandra, R., Caserta, L., Belletta, M., Tartaglione, M. T., Riegler, G., Biagi, F., Corazza, G. R., & Carratu, R. (2001) · Digestive and Liver Disease · doi:10.1016/s1590-8658(01)80045-1 · Cited by 66
Identification of a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae
Heelan, B. T., Allan, S., & Barnes, R. M. R. (1991) · Immunology Letters · doi:10.1016/0165-2478(91)90001-q · Cited by 42
Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases
Wiik, A. S. (2002) · Autoimmunity Reviews · doi:10.1016/s1568-9972(01)00007-6 · Cited by 31
Self-citation
Cited by
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
Microbial Influences in Inflammatory Bowel Diseases
Sartor, R. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.059 · Cited by 1,927
Le Berre, C., Honap, S., & Peyrin-Biroulet, L. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00966-2 · Cited by 1,643
A Proposed Classification of the Immunological Diseases
McGonagle, D., & McDermott, M. F. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030297 · Cited by 840
Tlaskalová-Hogenová, H., Štěpánková, R., Kozáková, H., Hudcovic, T., Vannucci, L., Tučková, L., Rossmann, P., Hrnčíř, T., Kverka, M., Zákostelská, Z., et al. (2011) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.67 · Cited by 693
Metadata
- Authors
- Israeli, E., Grotto, I., Gilburd, B., Balicer, R. D., Goldin, E., Wiik, A., & Shoenfeld, Y.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2005-08-11
- Volume
- 54
- Issue
- 9
- Pages
- 1232-1236
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2005699689
- Cited by
- 322
- References
- 22
- FWCI
- 12.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.